140 related articles for article (PubMed ID: 25168278)
1. Effect of high-dose statin loading on biomarkers related to inflammation and renal injury in patients hospitalized with acute heart failure. Randomized, controlled, open-label, prospective pilot study.
Oh J; Kang SM; Hong N; Youn JC; Park S; Lee SH; Choi D
Circ J; 2014; 78(10):2447-54. PubMed ID: 25168278
[TBL] [Abstract][Full Text] [Related]
2. Is high-dose statin loading effective for acute decompensated heart failure? Insight of inflammation and acute kidney injury.
Akiyama E; Kosuge M; Kimura K
Circ J; 2014; 78(10):2380-1. PubMed ID: 25231223
[No Abstract] [Full Text] [Related]
3. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial.
Kim JS; Kim J; Choi D; Lee CJ; Lee SH; Ko YG; Hong MK; Kim BK; Oh SJ; Jeon DW; Yang JY; Cho JR; Lee NH; Cho YH; Cho DK; Jang Y
JACC Cardiovasc Interv; 2010 Mar; 3(3):332-9. PubMed ID: 20298994
[TBL] [Abstract][Full Text] [Related]
4. Immediate administration of atorvastatin decreased the serum MMP-2 level and improved the prognosis for acute heart failure.
Shirakabe A; Asai K; Hata N; Yokoyama S; Shinada T; Kobayashi N; Tomita K; Tsurumi M; Matsushita M; Mizuno K
J Cardiol; 2012 May; 59(3):374-82. PubMed ID: 22402418
[TBL] [Abstract][Full Text] [Related]
5. Statin and the risk of renal-related serious adverse events: Analysis from the IDEAL, TNT, CARDS, ASPEN, SPARCL, and other placebo-controlled trials.
Bangalore S; Fayyad R; Hovingh GK; Laskey R; Vogt L; DeMicco DA; Waters DD;
Am J Cardiol; 2014 Jun; 113(12):2018-20. PubMed ID: 24793673
[TBL] [Abstract][Full Text] [Related]
6. Long-term statin therapy in patients with systolic heart failure and normal cholesterol: effects on elevated serum markers of collagen turnover, inflammation, and B-type natriuretic peptide.
Abulhul E; McDonald K; Martos R; Phelan D; Spiers JP; Hennessy M; Baugh J; Watson C; O'Loughlin C; Ledwidge M
Clin Ther; 2012 Jan; 34(1):91-100. PubMed ID: 22154198
[TBL] [Abstract][Full Text] [Related]
7. Administration of a loading dose of atorvastatin before percutaneous coronary intervention prevents inflammation and reduces myocardial injury in STEMI patients: a randomized clinical study.
Liu HL; Yang Y; Yang SL; Luo JP; Li H; Jing LM; Shen ZQ
Clin Ther; 2013 Mar; 35(3):261-72. PubMed ID: 23410871
[TBL] [Abstract][Full Text] [Related]
8. Atorvastatin therapy is associated with reduced levels of N-terminal prohormone brain natriuretic peptide and improved cardiac function in patients with heart failure.
Stypmann J; Schubert A; Welp H; Schulte H; Assmann G; Breithardt G; Nofer JR
Clin Cardiol; 2008 Oct; 31(10):478-81. PubMed ID: 18855352
[TBL] [Abstract][Full Text] [Related]
9. Short-term high-dose atorvastatin for periprocedural myocardial infarction prevention in patients with renal dysfunction.
Toso A; Leoncini M; Maioli M; Gallopin M; Tedeschi D; Amato M; Bellandi F
J Cardiovasc Med (Hagerstown); 2011 May; 12(5):318-21. PubMed ID: 21045713
[TBL] [Abstract][Full Text] [Related]
10. High-dose atorvastatin on the pharmacodynamic effects of double-dose clopidogrel in patients undergoing percutaneous coronary interventions: The ACHIDO (Atorvastatin and Clopidogrel HIgh DOse in stable patients with residual high platelet activity) study.
Leoncini M; Toso A; Maioli M; Angiolillo DJ; Giusti B; Marcucci R; Abbate R; Bellandi F
JACC Cardiovasc Interv; 2013 Feb; 6(2):169-79. PubMed ID: 23428009
[TBL] [Abstract][Full Text] [Related]
11. Effect of atorvastatin vs. rosuvastatin on cardiac sympathetic nerve activity in non-diabetic patients with dilated cardiomyopathy.
Tsutamoto T; Sakai H; Ibe K; Yamaji M; Kawahara C; Nakae I; Fujii M; Yamamoto T; Horie M
Circ J; 2011; 75(9):2160-6. PubMed ID: 21737951
[TBL] [Abstract][Full Text] [Related]
12. Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction.
Briguori C; Visconti G; Focaccio A; Golia B; Chieffo A; Castelli A; Mussardo M; Montorfano M; Ricciardelli B; Colombo A
J Am Coll Cardiol; 2009 Dec; 54(23):2157-63. PubMed ID: 19664895
[TBL] [Abstract][Full Text] [Related]
13. Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Substudy.
Gibson CM; Pride YB; Hochberg CP; Sloan S; Sabatine MS; Cannon CP;
J Am Coll Cardiol; 2009 Dec; 54(24):2290-5. PubMed ID: 19958964
[TBL] [Abstract][Full Text] [Related]
14. Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trial.
Patti G; Ricottini E; Nusca A; Colonna G; Pasceri V; D'Ambrosio A; Montinaro A; Di Sciascio G
Am J Cardiol; 2011 Jul; 108(1):1-7. PubMed ID: 21529740
[TBL] [Abstract][Full Text] [Related]
15. Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. The ROMA II trial.
Sardella G; Lucisano L; Mancone M; Conti G; Calcagno S; Stio RE; Pennacchi M; Biondi-Zoccai G; Canali E; Fedele F
Int J Cardiol; 2013 Oct; 168(4):3715-20. PubMed ID: 23849964
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of intensive statin therapy on N-terminal pro-BNP level in non-ST-segment elevation acute myocardial infarction patients.
Shehata M; Samir A; Dardiri M
J Interv Cardiol; 2017 Dec; 30(6):514-521. PubMed ID: 28812321
[TBL] [Abstract][Full Text] [Related]
17. On-Statin Resistin, Leptin, and Risk of Recurrent Coronary Events After Hospitalization for an Acute Coronary Syndrome (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Study).
Khera AV; Qamar A; Murphy SA; Cannon CP; Sabatine MS; Rader DJ
Am J Cardiol; 2015 Sep; 116(5):694-8. PubMed ID: 26119654
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of ezetimibe-plus-statin therapy on low-density lipoprotein cholesterol levels as compared with double-dose statin therapy in patients with coronary artery disease.
Okada K; Iwahashi N; Endo T; Himeno H; Fukui K; Kobayashi S; Shimizu M; Iwasawa Y; Morita Y; Wada A; Shigemasa T; Mochida Y; Shimizu T; Sawada R; Uchino K; Umemura S; Kimura K
Atherosclerosis; 2012 Oct; 224(2):454-6. PubMed ID: 22892323
[TBL] [Abstract][Full Text] [Related]
19. Intensive statin therapy for Chinese patients with coronary artery disease undergoing percutaneous coronary intervention (ISCAP study): rationale and design.
Liu P; Jiang J; Li J; Hong T; Zhang Y; Yu R; Jia J; Huo Y
Catheter Cardiovasc Interv; 2012 May; 79(6):967-71. PubMed ID: 22514150
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of high-dose atorvastatin pretreatment on renal function in patients with acute ST-segment elevation myocardial infarction undergoing emergency percutaneous coronary intervention.
Li W; Fu X; Wang Y; Li X; Yang Z; Wang X; Geng W; Gu X; Hao G; Jiang Y; Fan W; Wu W; Li S
Cardiology; 2012; 122(3):195-202. PubMed ID: 22854323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
